Cargando…
人源化靶向CD19 CAR-T细胞治疗复发/难治急性B淋巴细胞白血病的有效性及安全性
OBJECTIVE: This study aimed to evaluate the safety and efficacy of humanized CD19-targeted chimeric antigen receptor T-cell（CAR-T）in patients with relapsed/refractory acute B cell lymphoblastic leukemia（R/R B-ALL）. METHODS: The clinical data of 41 patients with R/R B-ALL treated with humanized CD19-...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593019/ https://www.ncbi.nlm.nih.gov/pubmed/36709149 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.08.006 |